Anna L. Bowman

758 total citations
22 papers, 604 citations indexed

About

Anna L. Bowman is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anna L. Bowman has authored 22 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anna L. Bowman's work include Cannabis and Cannabinoid Research (11 papers), Protein Structure and Dynamics (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Anna L. Bowman is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Protein Structure and Dynamics (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Anna L. Bowman collaborates with scholars based in United States, United Kingdom and Greece. Anna L. Bowman's co-authors include Alexandros Makriyannis, Heather A. Carlson, Adrian J. Mulholland, Michael G. Lerner, Haizhen A. Zhong, Zaneta Nikolovska‐Coleska, Ian Grant, Shaomeng Wang, Nikolai Zvonok and Vidyanand G. Shukla and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Biochemistry.

In The Last Decade

Anna L. Bowman

21 papers receiving 599 citations

Peers

Countries citing papers authored by Anna L. Bowman

Since Specialization

Citations

This map shows the geographic impact of Anna L. Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Bowman more than expected).

Fields of papers citing papers by Anna L. Bowman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Bowman. The network helps show where Anna L. Bowman may publish in the future.

Co-authorship network of co-authors of Anna L. Bowman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L. Bowman. A scholar is included among the top collaborators of Anna L. Bowman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L. Bowman. Anna L. Bowman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Membrane phospholipid bilayer as a determinant of monoacylglycerol lipase kinetic profile and conformational repertoire 2013 ·Protein Science ·Mahmoud L. Nasr, Xiaomeng Shi, Anna L. Bowman, Michael J. Johnson, Nikolai Zvonok, David R. Janero, Kiran Vemuri, Thomas E. Wales, John R. Engen, Alexandros Makriyannis	35
2	C3-Heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor 2012 ·Bioorganic & Medicinal Chemistry Letters ·Darryl D. Dixon, Marcus A. Tius, Ganesh A. Thakur, Han Zhou, Anna L. Bowman, Vidyanand G. Shukla, (unknown), Alexandros Makriyannis	23
3	Highly Predictive Ligand‐based Pharmacophore and Homology Models of ABHD6 2012 ·Chemical Biology & Drug Design ·Anna L. Bowman, Alexandros Makriyannis	10
4	Biochemical and Mass Spectrometric Characterization of Human N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition 2012 ·PLoS ONE ·(unknown), Nikolai Zvonok, (unknown), Subramanian K. Vadivel, Anna L. Bowman, Alexandros Makriyannis	30
5	Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase 2012 ·Journal of Medicinal Chemistry ·Shakiru O. Alapafuja, Spyros P. Nikas, (unknown), Vidyanand G. Shukla, Mahmoud L. Nasr, Anna L. Bowman, Nikolai Zvonok, Jing Li, Xiaomeng Shi, John R. Engen, Alexandros Makriyannis	45
6	Heteroadamantyl Cannabinoids 2010 ·Journal of Medicinal Chemistry ·Darryl D. Dixon, D. Sethumadhavan, Tore Benneche, (unknown), Marcus A. Tius, Ganesh A. Thakur, Anna L. Bowman, JodiAnne T. Wood, Alexandros Makriyannis	35
7	Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9β-Hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist 2010 ·Journal of Medicinal Chemistry ·Spyros P. Nikas, Shakiru O. Alapafuja, Ioannis Papanastasiou, Carol A. Paronis, Vidyanand G. Shukla, Demetris P. Papahatjis, Anna L. Bowman, H. Aneetha, Xiuwen Han, Alexandros Makriyannis	48
8	Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes 2009 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Elvis K. Tiburu, Anna L. Bowman, Jochem Struppe, David R. Janero, Hava Avraham, Alexandros Makriyannis	18
9	Refined homology model of monoacylglycerol lipase: toward a selective inhibitor 2009 ·Journal of Computer-Aided Molecular Design ·Anna L. Bowman, Alexandros Makriyannis	10
10	Development of novel tail-modified anandamide analogs 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Chen Li, Subramanian K. Vadivel, Anna L. Bowman, Alexandros Makriyannis	8
11	QM/MM simulations predict a covalent intermediate in the hen egg white lysozyme reaction with its natural substrate 2008 ·Chemical Communications ·Anna L. Bowman, Ian Grant, Adrian J. Mulholland	61
12	Bornyl- and Isobornyl-Δ⁸-tetrahydrocannabinols: A Novel Class of Cannabinergic Ligands 2008 ·Journal of Medicinal Chemistry ·Dai Lu, Zhixiong Guo, R. Duclos, Anna L. Bowman, Alexandros Makriyannis	20
13	Small Molecule Inhibitors of the MDM2-p53 Interaction Discovered by Ensemble-Based Receptor Models 2007 ·Journal of the American Chemical Society ·Anna L. Bowman, Zaneta Nikolovska‐Coleska, Haizhen A. Zhong, Shaomeng Wang, Heather A. Carlson	100
14	Molecular Determinants of Xenobiotic Metabolism: QM/MM Simulation of the Conversion of 1-Chloro-2,4-dinitrobenzene Catalyzed by M1-1 Glutathione S-Transferase 2007 ·Biochemistry ·Anna L. Bowman, Lars Ridder, Ivonne M.C.M. Rietjens, Jacques Vervoort, Adrian J. Mulholland	28
15	Protein Flexibility and Species Specificity in Structure-Based Drug Discovery: Dihydrofolate Reductase as a Test System 2007 ·Journal of the American Chemical Society ·Anna L. Bowman, Michael G. Lerner, Heather A. Carlson	39
16	Incorporating Dynamics in E. coli Dihydrofolate Reductase Enhances Structure-Based Drug Discovery 2007 ·Journal of Chemical Information and Modeling ·Michael G. Lerner, Anna L. Bowman, Heather A. Carlson	25
17	Simulating Enzyme‐Catalyzed Reactions 2007 ·ChemInform ·Anna L. Bowman, Adrian J. Mulholland	1
18	MM and QM/MM Modeling of Threonyl-tRNA Synthetase: Model Testing and Simulations 2004 ·Structural Chemistry ·Jolanta Żurek, Anna L. Bowman, W. Andrzej Sokalski, Adrian J. Mulholland	20
19	Recording industrial landscapes 2004 ·City ·Anna L. Bowman	1
20	Reports, Interviews, Reviews 2001 ·City ·Michael Keith, Leslie Budd, Martin Harris, Neil Ward, Anna L. Bowman	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact